Global Cataplexy Treatment Market, By Treatment (Sodium Oxybate, Tricyclic Antidepressant, Amphetamines, Selective Serotonin Uptake Reinhibitors (SSRIs), Modafinil), Dosage (Tablet, Solution, Capsule,  Others), Route of Administration (Oral, Other), Diagnosis (Physical Evaluation, Written Evaluation, Polysomnogram, Multiple Sleep Latency Test (MSLT)), Symptoms (Drooping Eyelids, Jaw Tremor, Facial Twitching, Flickering, Speech Difficulty, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.